Brief: Cue Biopharma Inc Posts Qtrly Collaboration Revenue $2.7 Million Versus $1.1 Million

Cue Biopharma

17/08/2021 21:48

Aug 17 (Reuters) - Cue Biopharma Inc  CUE.O :
    * CUE BIOPHARMA REPORTS SECOND QUARTER 2021 RESULTS, RECENT
DATA
UPDATES OF CUE-101 PHASE 1 DOSE ESCALATION AND EXPANSION STUDY,
PLATFORM PROGRESS AND BUSINESS HIGHLIGHTS
    * CUE BIOPHARMA INC QTRLY NET LOSS PER COMMON SHARE $ 0.33
    * CUE BIOPHARMA INC QTRLY COLLABORATION REVENUE $2.7 MILLION
VERSUS $1.1 MILLION

Source text for Eikon:  ID:nGNX1Y95pC 
Further company coverage:  CUE.O